OBJECTIVE: This study investigates the relationship between anxiety symptoms and adaptive function in children with chromosome 22q11.2 deletion syndrome (22q11.2DS). METHODS: Seventy-eight children between 7 and 14 years of age with 22q11.2DS and 36 typically developing (TD) children without known genetic syndromes participated in a larger study of neurocognition. Parents completed questionnaires about their child's anxiety symptoms (Behavior Assessment System for Children, 2nd edition [BASC-2] and Spence Children's Anxiety Scale [SCAS]) and adaptive functioning (BASC-2 and Adaptive Behavior Assessment System, 2nd edition). Within the 22q11.2DS group, different DSM-IV anxiety domains were also analyzed using SCAS subscales. RESULTS: Based on parent report, 19% of children with 22q11.2DS had a prior diagnosis of an anxiety disorder versus 58% with at least 1 elevated anxiety score (BASC-2 or SCAS). Mean BASC-2 anxiety scores were significantly higher in 22q11.2DS (55.6 ± 12.5) than in TD children (48.3 ± 10; p = .003), and a greater percentage of children with 22q11.2DS (37%) had an elevated BASC-2 anxiety scores compared with TD children (14%; p = .01). Higher anxiety scores were related to lower adaptive function (r = -.27; p = .015), but there was no relationship between Wechsler Intelligence Scale for Children, 4th edition Full Scale Intelligence Quotient and BASC-2 adaptive skills (r = -.06; p = .6) in the 22q11.2DS group. For the individual SCAS anxiety subscales, panic-agoraphobia (r = -.38; p = .03), physical injury (r = -.34; p = .05), and obsessive-compulsive disorder (r = -.47; p = .005) were significantly negatively related to adaptive function in 22q11.2DS. CONCLUSION: Despite the known risk, anxiety is underidentified in children with 22q11.2DS. The presence of anxiety symptoms, but not intelligence levels, in children with 22q11.2DS negatively correlated with adaptive function and impacts everyday living skills.
OBJECTIVE: This study investigates the relationship between anxiety symptoms and adaptive function in children with chromosome 22q11.2 deletion syndrome (22q11.2DS). METHODS: Seventy-eight children between 7 and 14 years of age with 22q11.2DS and 36 typically developing (TD) children without known genetic syndromes participated in a larger study of neurocognition. Parents completed questionnaires about their child's anxiety symptoms (Behavior Assessment System for Children, 2nd edition [BASC-2] and Spence Children's Anxiety Scale [SCAS]) and adaptive functioning (BASC-2 and Adaptive Behavior Assessment System, 2nd edition). Within the 22q11.2DS group, different DSM-IV anxiety domains were also analyzed using SCAS subscales. RESULTS: Based on parent report, 19% of children with 22q11.2DS had a prior diagnosis of an anxiety disorder versus 58% with at least 1 elevated anxiety score (BASC-2 or SCAS). Mean BASC-2 anxiety scores were significantly higher in 22q11.2DS (55.6 ± 12.5) than in TD children (48.3 ± 10; p = .003), and a greater percentage of children with 22q11.2DS (37%) had an elevated BASC-2 anxiety scores compared with TD children (14%; p = .01). Higher anxiety scores were related to lower adaptive function (r = -.27; p = .015), but there was no relationship between Wechsler Intelligence Scale for Children, 4th edition Full Scale Intelligence Quotient and BASC-2 adaptive skills (r = -.06; p = .6) in the 22q11.2DS group. For the individual SCAS anxiety subscales, panic-agoraphobia (r = -.38; p = .03), physical injury (r = -.34; p = .05), and obsessive-compulsive disorder (r = -.47; p = .005) were significantly negatively related to adaptive function in 22q11.2DS. CONCLUSION: Despite the known risk, anxiety is underidentified in children with 22q11.2DS. The presence of anxiety symptoms, but not intelligence levels, in children with 22q11.2DS negatively correlated with adaptive function and impacts everyday living skills.
Authors: Doron Gothelf; Carl Feinstein; Tracy Thompson; Eugene Gu; Lauren Penniman; Ellen Van Stone; Hower Kwon; Stephan Eliez; Allan L Reiss Journal: Am J Psychiatry Date: 2007-04 Impact factor: 18.112
Authors: Amy Krain Roy; Roma A Vasa; Maggie Bruck; Karin Mogg; Brendan P Bradley; Michael Sweeney; R Lindsey Bergman; Erin B McClure-Tone; Daniel S Pine Journal: J Am Acad Child Adolesc Psychiatry Date: 2008-10 Impact factor: 8.829
Authors: Bernet M Elzinga; Karin Roelofs; Marieke S Tollenaar; Patricia Bakvis; Johannes van Pelt; Philip Spinhoven Journal: Psychoneuroendocrinology Date: 2007-12-21 Impact factor: 4.905
Authors: Laura Mercer-Rosa; Stephen M Paridon; Mark A Fogel; Jack Rychik; Ronn E Tanel; Huaqing Zhao; Xuemei Zhang; Wei Yang; Justine Shults; Elizabeth Goldmuntz Journal: Circ Cardiovasc Genet Date: 2015-01-05
Authors: Yi Deng; Naomi J Goodrich-Hunsaker; Margarita Cabaral; David G Amaral; Michael H Buonocore; Danielle Harvey; Kristopher Kalish; Owen T Carmichael; Cynthia M Schumann; Aaron Lee; Robert F Dougherty; Lee M Perry; Brian A Wandell; Tony J Simon Journal: Psychiatry Res Date: 2015-02-11 Impact factor: 3.222
Authors: David D Stephenson; Elliott A Beaton; Carl F Weems; Kathleen Angkustsiri; Tony J Simon Journal: Behav Brain Res Date: 2014-06-03 Impact factor: 3.332
Authors: Maude Schneider; Marco Armando; Maria Pontillo; Stefano Vicari; Martin Debbané; Frauke Schultze-Lutter; Stephan Eliez Journal: World Psychiatry Date: 2016-10 Impact factor: 49.548
Authors: Julia A Scott; Naomi Goodrich-Hunsaker; Kristopher Kalish; Aaron Lee; Michael R Hunsaker; Cynthia M Schumann; Owen T Carmichael; Tony J Simon Journal: J Psychiatry Neurosci Date: 2016-04 Impact factor: 6.186